Home » About PXV »

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 373 other followers


Twitter Feed


PXV Partner Thomas Philippe was interviewed by Economic Times in relation to the  share purchase agreement between Japanese drugmaker Daiichi Sankyo and Ranbaxy Labs.

GT Thomas Philippe, partner at PXV Law Partners, said that the most unusual part of the agreement is that the knowledge of the company here has been narrowed down to mean just Malvinder Singh. “It is very surprising that no other senior managerial personnel was included for this purpose.”

The whole article can be accessed here:



Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: